These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3677224)

  • 1. Inhibitors of the arachidonate cascade from Allium chinense and their effect on in vitro platelet aggregation.
    Goda Y; Shibuya M; Sankawa U
    Chem Pharm Bull (Tokyo); 1987 Jul; 35(7):2668-74. PubMed ID: 3677224
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential effects of cyclo-oxygenase inhibitors and thromboxane synthase inhibitors on rabbit platelet aggregation: evidence for the importance of prostaglandin endoperoxides as mediators in arachidonate-induced aggregation but not in collagen-induced aggregation.
    Wallis RB; Zelaschi D
    Biochem Soc Trans; 1980 Dec; 8(6):726-7. PubMed ID: 6780392
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanism of action of antiplatelet medication].
    Navarro JL; Frade FJ; Alava I; Obispo T; Trejo R; Jiménez C; Cesar J
    Sangre (Barc); 1984; 29(4-C):817-32. PubMed ID: 6096974
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of arachidonate-induced human platelet aggregation by a single low oral dose of aspirin in combination with a thromboxane synthase inhibitor.
    Cerletti C; Rajtar G; Bertelé V; de Gaetano G
    Thromb Haemost; 1984 Oct; 52(2):215. PubMed ID: 6441306
    [No Abstract]   [Full Text] [Related]  

  • 6. Antagonism of hyperthermogenic agents by L 8027, an inhibitor of prostaglandin and thromboxane synthetase.
    Clark WG; Lipton JM
    Proc Soc Exp Biol Med; 1979 Apr; 160(4):473-6. PubMed ID: 313058
    [No Abstract]   [Full Text] [Related]  

  • 7. An overview of antiplatelet and antithrombotic drugs.
    Verstraete M; Dejana E; Fuster V; Lapetina E; Moncada S; Mustard JF; Tans G; Vargaftig BB
    Haemostasis; 1985; 15(2):89-99. PubMed ID: 3159632
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of thromboxane synthetase inhibitors on aggregation of rabbit platelets.
    Naito J; Komatsu H; Ujiie A; Hamano S; Kubota T; Tsuboshima M
    Eur J Pharmacol; 1983 Jul; 91(1):41-8. PubMed ID: 6413227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement of ADP for arachidonic acid-induced platelet aggregation: studies with selective thromboxane-synthase inhibitors.
    Cerletti C; Minoldo S; Bucchi F; Del Maschio A; de Gaetano G
    Biochem Pharmacol; 1986 Apr; 35(7):1201-3. PubMed ID: 3083818
    [No Abstract]   [Full Text] [Related]  

  • 10. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour.
    Parry MJ
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):23S-29S. PubMed ID: 6401997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro.
    De Clerck F; Beetens J; de Chaffoy de Courcelles D; Freyne E; Janssen PA
    Thromb Haemost; 1989 Feb; 61(1):35-42. PubMed ID: 2546278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation by dazoxiben, a thromboxane synthetase inhibitor, of platelet aggregation inhibitory activity of a thromboxane receptor antagonist and of prostacyclin.
    Bertele V; De Gaetano G
    Eur J Pharmacol; 1982 Dec; 85(3-4):331-3. PubMed ID: 6295787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of imidazole and 9,11-azoprosta-5,13-dienoic acid. Two selective thromboxane synthetase inhibitors.
    Fitzpatrick FA; Gorman RR
    Biochim Biophys Acta; 1978 Mar; 539(2):162-72. PubMed ID: 629996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzodiazepine analogues inhibit arachidonate-induced aggregation and thromboxane synthesis in human platelets.
    Fonlupt P; Croset M; Lagarde M
    Br J Pharmacol; 1990 Dec; 101(4):920-4. PubMed ID: 1964822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin and thromboxane biosynthesis inhibitors.
    Gryglewski RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1977; 297 Suppl 1():S85-8. PubMed ID: 859658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular action of drugs affecting platelet functions (author's transl)].
    Verstraete M
    Rev Med Brux; 1981 Mar; 2(3):301-8. PubMed ID: 6262895
    [No Abstract]   [Full Text] [Related]  

  • 18. Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders.
    Gresele P; Blockmans D; Deckmyn H; Vermylen J
    J Pharmacol Exp Ther; 1988 Jul; 246(1):301-7. PubMed ID: 3134542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxane synthase inhibition potentiates washed platelet activation by endogenous and exogenous arachidonic acid.
    Patscheke H
    Biochem Pharmacol; 1985 Apr; 34(8):1151-6. PubMed ID: 3922373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase.
    Lee JJ; Yu JY; Lee JH; Zhang WY; Kim TJ; Myung CS; Yun YP
    Arch Pharm Res; 2010 Mar; 33(3):387-94. PubMed ID: 20361303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.